UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Epigenetic Modulation of Self-Renewal Capacity of Leukemic Stem Cells and Implications for Chemotherapy

Epigenomes, 2020-03, Vol.4 (1), p.3

2020

Volltextzugriff (PDF)

Enhancement of the Antileukemic Action of the Inhibitors of DNA and Histone Methylation: 5-Aza-2'-Deoxycytidine and 3-Deazaneplanocin-A by Vitamin C

Epigenomes, 2021-03, Vol.5 (2), p.7

2021

Volltextzugriff (PDF)

Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer

BMC cancer, 2008-05, Vol.8 (1), p.128-128, Article 128

2008

Volltextzugriff (PDF)

Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation

Clinical epigenetics, 2014-10, Vol.6 (1), p.19-19, Article 19

2014

Volltextzugriff (PDF)

3-Deazauridine enhances the antileukemic action of 5-aza-2′-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase

Leukemia research, 2011-01, Vol.35 (1), p.110-118

2011

Volltextzugriff (PDF)

Inhibition of DNA and Histone Methylation by 5-Aza-2'-Deoxycytidine (Decitabine) and 3-Deazaneplanocin-A on Antineoplastic Action and Gene Expression in Myeloid Leukemic Cells

Frontiers in oncology, 2017-02, Vol.7, p.19-19

2017

Volltextzugriff (PDF)

Synergistic antileukemic action of a combination of inhibitors of DNA methylation and histone methylation

Leukemia research, 2012-08, Vol.36 (8), p.1049-1054

2012

Volltextzugriff (PDF)

Antineoplastic action of 5-aza-2′-deoxycytidine and phenylbutyrate on human lung carcinoma cells

Anti-cancer drugs, 2002-09, Vol.13 (8), p.869-874

2002

Volltextzugriff (PDF)

Epigenetic action of decitabine (5-aza-2′-deoxycytidine) is more effective against acute myeloid leukemia than cytotoxic action of cytarabine (ARA-C)

Leukemia research, 2013-08, Vol.37 (8), p.980-984

2013

Volltextzugriff (PDF)

Synergistic effect of 5-Aza-2'-deoxycytidine and genistein in combination against leukemia

Oncology research, 2008-01, Vol.17 (5), p.223

2008

Volltextzugriff (PDF)

Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine

Cancer chemotherapy and pharmacology, 2009-02, Vol.63 (3), p.411-416

2009

Volltextzugriff (PDF)

Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells

Leukemia research, 2003-05, Vol.27 (5), p.437-444

2003

Volltextzugriff (PDF)

Enhancement of antineoplastic action of 5-aza-2′-deoxycytidine by zebularine on L1210 leukemia

Anti-cancer drugs, 2005-03, Vol.16 (3), p.301-308

2005

Volltextzugriff (PDF)

DNA methylation of retinoic acid receptor β in breast cancer and possible therapeutic role of 5-aza-2ʼ-deoxycytidine

Anti-cancer drugs, 1999-06, Vol.10 (5), p.471-476

1999

Volltextzugriff (PDF)

Enhancement of Antineoplastic Action of 5-Aza-2′-deoxycytidine by Phenylbutyrate on L1210 Leukemic Cells

Leukemia & lymphoma, 2004-01, Vol.45 (1), p.147-154

2004

Volltextzugriff (PDF)

Abstract LB-296: Synergistic anticancer action of inhibitor of DNA methylation 5-aza-2-deocycytidine and EZH2 histone methylase inhibitor 3-deazaneplanocin A

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.LB-296-LB-296

2010

Volltextzugriff (PDF)

Pilot phase I-II study on 5-aza-2'-deoxycytidine (Decitabine) in patients with metastatic lung cancer

Anti-cancer drugs, 1997-04, Vol.8 (4), p.358-368

1997

Volltextzugriff (PDF)

Cell cycle effects and cellular pharmacology of 5-AZA-2'-deoxycytidine

Cancer chemotherapy and pharmacology, 1984-10, Vol.13 (3), p.191-194

1984

Volltextzugriff (PDF)

Enhancement of the antileukemic activity of 5-aza-2′-deoxycytidine by cyclopentenyl cytosine in HL-60 leukemic cells

Anti-cancer drugs, 1994-04, Vol.5 (2), p.223-228

1994

Volltextzugriff (PDF)

Comparison of antineoplastic activity of 2',2'-difluorodeoxycytidine and cytosine arabinoside against human myeloid and lymphoid leukemic cells

Anti-cancer drugs, 1991-02, Vol.2 (1), p.49-56

1991

Volltextzugriff (PDF)

Comparison of antineoplastic activity of cytosine arabinoside and 5-aza-2′-deoxycytidine against human leukemic cells of different phenotype

Leukemia research, 1990, Vol.14 (9), p.755-760

1990

Volltextzugriff (PDF)

Interaction of 5-aza-2'-deoxycytidine with amsacrine or 1,25-dihydroxyvitamin D3 on HL-60 myeloid leukemic cells and inhibitors of cytidine deaminase

Leukemia, 1993-05, Vol.7 Suppl 1, p.17

1993

Volltextzugriff (PDF)

Chemotherapy of L1210 and L1210/ARA-C leukemia with 5-aza-2'-deoxycytidine and 3-deazauridine

Cancer chemotherapy and pharmacology, 1989, Vol.25 (1), p.51-54

1989

Volltextzugriff (PDF)

Pilot phase l-ll study on 5-aza-2ʼ-deoxycytidine (Decitabine) in patients with metastatic lung cancer

Anti-cancer drugs, 1997-04, Vol.8 (4), p.358-368

1997

Volltextzugriff (PDF)

Comparison of the antileukemic activity of 5-aza-2′-deoxycytidine, 1-β- d-arabinofuranosylcytosine and 5-azacytidine against L1210 leukemia

Leukemia research, 1984, Vol.8 (6), p.1043-1049

1984

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Oncology
(24)
Humans
(21)
Azacitidine - Analogs & Derivatives
(20)
Animals
(13)
Chemotherapy
(13)
Mice
(13)
Male
(12)
5-Aza-2′-Deoxycytidine
(11)
Azacitidine - Pharmacology
(11)
Decitabine
(11)
Dna Methylation
(11)
Antineoplastic Agents
(10)
Biological And Medical Sciences
(10)
Drug Synergism
(10)
Medical Sciences
(10)
Pharmacology & Pharmacy
(10)
Pharmacology. Drug Treatments
(10)
Azacitidine - Therapeutic Use
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epigenetic Modulation of Self-Renewal Capacity of Leukemic Stem Cells and Implications for Chemotherapy

Enhancement of the Antileukemic Action of the Inhibitors of DNA and Histone Methylation: 5-Aza-2'-Deoxycytidine and 3-Deazaneplanocin-A by Vitamin C

Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer

Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation

3-Deazauridine enhances the antileukemic action of 5-aza-2′-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase

Inhibition of DNA and Histone Methylation by 5-Aza-2'-Deoxycytidine (Decitabine) and 3-Deazaneplanocin-A on Antineoplastic Action and Gene Expression in Myeloid Leukemic Cells

Synergistic antileukemic action of a combination of inhibitors of DNA methylation and histone methylation

Antineoplastic action of 5-aza-2′-deoxycytidine and phenylbutyrate on human lung carcinoma cells

Epigenetic action of decitabine (5-aza-2′-deoxycytidine) is more effective against acute myeloid leukemia than cytotoxic action of cytarabine (ARA-C)

Synergistic effect of 5-Aza-2'-deoxycytidine and genistein in combination against leukemia

Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine

Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells

Enhancement of antineoplastic action of 5-aza-2′-deoxycytidine by zebularine on L1210 leukemia

DNA methylation of retinoic acid receptor β in breast cancer and possible therapeutic role of 5-aza-2ʼ-deoxycytidine

Enhancement of Antineoplastic Action of 5-Aza-2′-deoxycytidine by Phenylbutyrate on L1210 Leukemic Cells

Abstract LB-296: Synergistic anticancer action of inhibitor of DNA methylation 5-aza-2-deocycytidine and EZH2 histone methylase inhibitor 3-deazaneplanocin A

Pilot phase I-II study on 5-aza-2'-deoxycytidine (Decitabine) in patients with metastatic lung cancer

Cell cycle effects and cellular pharmacology of 5-AZA-2'-deoxycytidine

Enhancement of the antileukemic activity of 5-aza-2′-deoxycytidine by cyclopentenyl cytosine in HL-60 leukemic cells

Comparison of antineoplastic activity of 2',2'-difluorodeoxycytidine and cytosine arabinoside against human myeloid and lymphoid leukemic cells

Comparison of antineoplastic activity of cytosine arabinoside and 5-aza-2′-deoxycytidine against human leukemic cells of different phenotype

Interaction of 5-aza-2'-deoxycytidine with amsacrine or 1,25-dihydroxyvitamin D3 on HL-60 myeloid leukemic cells and inhibitors of cytidine deaminase

Chemotherapy of L1210 and L1210/ARA-C leukemia with 5-aza-2'-deoxycytidine and 3-deazauridine

Pilot phase l-ll study on 5-aza-2ʼ-deoxycytidine (Decitabine) in patients with metastatic lung cancer

Comparison of the antileukemic activity of 5-aza-2′-deoxycytidine, 1-β- d-arabinofuranosylcytosine and 5-azacytidine against L1210 leukemia

Suchergebnisse filtern